Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes

Scandinavian Journal of Immunology

Volumn 56, Issue 6, 2002, Pages 593-601

  Matsunaga, T ^a   Ishida, T ^a   Takekawa, M ^a,b   Nishimura, S ^a   Adachi, M ^a   Imai, K ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; APOPTOSIS INHIBITOR; CD63 ANTIGEN; LIPOPOLYSACCHARIDE; PROTEASOME; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTOPHAN; VACCINE;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; BLOOD; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG EFFICACY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; NERVE CELL; PRIORITY JOURNAL; PROTEIN FAMILY; UPREGULATION;

APOPTOSIS; CELL DIFFERENTIATION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOPHENOTYPING; KINETICS; LIPOPOLYSACCHARIDES; MONOCYTES; MULTIENZYME COMPLEXES; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; POLYMERASE CHAIN REACTION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036454809     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01179.x     Document Type: Article

References (42)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen-presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
3. De Smedt T, Pajak B, Klaus GG et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol 1998;161:4476-9.
4. Manome H, Aiba S, Tagami H. Simple chemicals can induce maturation and apoptosis of dendritic cells. Immunology 1999;98:481-90.
5. Ishida T, Oyama T, Carbone DP, Gabrilovich DI. Defective function of Langerhans' cells in tumor-bearing animals is the result of defective maturation from hematopoietic progenitors. J Immunol 1998;161:4842-51.
6. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997;3:483-90.
7. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997;150:641-51.
8. Nestle FO, Alijagic S, Gilliet M et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
9. Morse MA et al. Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin Cancer Res 1999;5:1331-8.
10. De Smedt T, Pajak B, Muraille E et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-24.
11. Kabel PJ, de Haan-Meulman M, Voorbij HA, Kleingeld M, Knol EF, Drexhage HA. Accessory cells with a morphology and marker pattern of dendritic cells can be obtained from elutriator-purified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation. Immunobiology 1989;179:395-41.
12. Larsen CP, Ritchie SC, Pearson TC, Linsley PS, Lowry RP. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 1992;176:1215-20.
13. Inaba K, Witmer-Pack M, Inaba Met al. The tissue distribution of the B7-2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994;180:1849-60.
14. Ebner S, Lenz A, Reider D, Fritsch P, Schuler G, Romani N. Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. Immunobiology 1998;198:568-87.
15. Palucka KA, Taquet N, Sanchez-Chapuis F, Gluckman JC. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998;160:4587-95.
16. Hashimoto S, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000;96:2206-14.
17. Dietz AB, Bulur PA, Knutson G J, Matasic R, Vuk-Pavlovic S. Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem Biophys Res Commun 2000;275:731-8.
18. Ardeshna KM, Pizzey AR, Devereux S, Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000;96:1039-46.
19. Ishida T, Tsujisaki M, Hanzawa Y et al. Significance of erbB-2 gene product as a target molecule for cancer therapy. Scand J Immunol 1994;39:459-66.
20. Ishida T, Tsujisaki M, Hinoda Y, Imai K, Yachi A. Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product. Jpn J Cancer Res 1994;85:172-8.
21. Lutz MB, Kukutsch NA, Menges M, Rossner S, Schuler G. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur J Immunol 2000;30:1048-52.
22. Romani N, Reider D, Heure Met al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-51.
23. Futatani T, Miyawaki T, Tsukada Set al. Deficient expression of Burton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998;91:595-602.
24. Vorechovsky I, Vetrie D, Holland Jet al. Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-Q22. Genomics 1994;21:517-24.
25. Yasumoto K, Shibahara S. Molecular cloning of cDNA encoding a human TFEC isoform, a newly identified transcriptional regulator. Biochim Biophys Acta 1997; 1357:23-31.
26. Rehli M, Lichanska A, Cassady AI, Ostrowiski MC, Hume DA. TFEC is a macrophage-restricted member of the microphthalmia TFE subfamily of basic helix-loop-helix leucine zipper transcriptional factors. J Immunol 1999;162:1559-65.
27. Akioka H, Forsberg NE, Ishida N et al. Isolation and characterization of the HC8 subunit gene of the human proteasome. Biochem Biophys Res Commun 1995;207:318-23.
28. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997;158:2723-30.
29. Macagno A, Gilliet M, Sallusto F, Lanzavecchia A, Nestle FO, Groettrup M. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur J Immunol 1999;29:4037-42.
30. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243-6.
31. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-9.
32. Lambert LA, Gibson GR, Maloney M, Barth RJ Jr. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens. J Immunother 2001;24:232-6.
33. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:9482-7.
34. Regnault A, Lankar D, Lacabanne V et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999;189:371-80.
35. Sasaki S, Tsujisaki M, Jinnohara T et al. Human tumor growth suppression by apoptosis induced with anti-ErbB-2 chimeric monoclonal antibody. Jpn J Cancer Res 1998;89:562-70.
36. Salmon JE, Pricop L. Human receptors for immunoglobulin G. Arthritis Rheum 2001;44:739-50.
37. Mommaas AM, Mulder AA, Out CJ et al. Distribution of HLA class II molecules in epidermal Langerhans' cells in situ. Eur J Immunol 1995;25:520-5.
38. Woodhead VE, Binks MH, Chain BM, Katz DR. From sentinel to messenger: An extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology 1998;94:552-9.
39. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996;60:540-5.
40. Eilers A, Baccarini M, Horn F, Hipskind RA, Schnidler C, Decker T. A factor induced by differentiation signals in cells of the macrophage lineage binds to gamma interferon activation site. Mol Cell Biol 1994;14:1364-73.
41. Roy N, Mahadevan MS, McLean M et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-78.
42. Diez E, Yaraghi Z, MacKenzie A, Gros P. The neuronal apoptosis inhibitory protein (NAIP) is expressed in macrophages and is modulated after phagocytosis and during intracellular infection with Legionella pneumophilia. J Immunol 2000;164:1470-7.